Testicular cancer survivorship: research strategies and recommendations.

@article{Travis2010TesticularCS,
  title={Testicular cancer survivorship: research strategies and recommendations.},
  author={Lois B. Travis and Clair Beard and James M. Allan and Alv Andreas Dahl and Darren R Feldman and Jan Oldenburg and Gedske Daugaard and Jennifer L. Kelly and M. Eileen Dolan and Robyn E. Hannigan and Louis Sandy Constine and Kevin Charles Oeffinger and Paul Okunieff and Greg Armstrong and David Wiljer and Robert C. Miller and Jourik A. Gietema and Flora E van Leeuwen and Jacqueline P Williams and Craig R. Nichols and Lawrence Henry Einhorn and Sophie D Fossa},
  journal={Journal of the National Cancer Institute},
  year={2010},
  volume={102 15},
  pages={1114-30}
}
Testicular cancer represents the most curable solid tumor, with a 10-year survival rate of more than 95%. Given the young average age at diagnosis, it is estimated that effective treatment approaches, in particular, platinum-based chemotherapy, have resulted in an average gain of several decades of life. This success, however, is offset by the emergence of considerable long-term morbidity, including second malignant neoplasms, cardiovascular disease, neurotoxicity, nephrotoxicity, pulmonary… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 17 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 82 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 246 references

Treatmentspecific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer

  • AW van den Belt-Dusebout, R de Wit, JA Gietema
  • J Clin Oncol
  • 2007
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…